awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37367910-C030A372-9018-4807-931E-47F6E2F5BB81
Q37367910-C030A372-9018-4807-931E-47F6E2F5BB81
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37367910-C030A372-9018-4807-931E-47F6E2F5BB81
The cost-effectiveness of bevacizumab for the treatment of advanced ovarian cancer in Canada.
P2860
Q37367910-C030A372-9018-4807-931E-47F6E2F5BB81
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37367910-C030A372-9018-4807-931E-47F6E2F5BB81
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
20f3e4778b8f4b50e63277192bead4f60aca6403
P2860
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial.